Aardvark Therapeutics, Inc. (AARD)
5.38
-0.35
(-6.11%)
USD |
NASDAQ |
Sep 04, 16:00
5.19
-0.19
(-3.53%)
After-Hours: 20:00
Aardvark Therapeutics Net Income (Quarterly) : -14.39M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.39M |
| March 31, 2026 | -21.59M |
| December 31, 2025 | -17.60M |
| September 30, 2025 | -16.32M |
| June 30, 2025 | -14.37M |
| March 31, 2025 | -9.31M |
| Date | Value |
|---|---|
| December 31, 2024 | -8.779M |
| September 30, 2024 | -4.182M |
| June 30, 2024 | -5.449M |
| March 31, 2024 | -2.178M |
| December 31, 2023 | -2.041M |
| September 30, 2023 | -2.109M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.39M |
| EPS Diluted (Quarterly) | -0.6586 |
| Enterprise Value | 44.54M |
| Earnings Yield | -59.58% |
| Normalized Earnings Yield | -59.58 |